Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Apr 29;4(4):CD011050.
doi: 10.1002/14651858.CD011050.pub2.

Intravenous magnesium sulfate for treating children with acute asthma in the emergency department

Benedict Griffiths  1 , Kayleigh M Kew
Affiliations
Meta-Analysis

Intravenous magnesium sulfate for treating children with acute asthma in the emergency department

Benedict Griffiths et al. Cochrane Database Syst Rev. .

Abstract

Background: Acute asthma in children can be life-threatening and must be treated promptly in the emergency setting. Intravenous magnesium sulfate is recommended by various guidelines for cases of acute asthma that have not responded to first-line treatment with bronchodilators and steroids. The treatment has recently been shown to reduce the need for hospital admission for adults compared with placebo, but it is unclear whether it is equally effective for children.

Objectives: To assess the safety and efficacy of intravenous magnesium sulfate (IV MgSO4) in children treated for acute asthma in the emergency department (ED).

Search methods: We identified studies by searching the Cochrane Airways Review Group Specialised Register up to 23 February 2016. We also searched ClinicalTrials.gov and reference lists of other reviews, and we contacted study authors to ask for additional information.

Selection criteria: We included randomised controlled trials of children treated in the ED for exacerbations of asthma if they compared any dose of IV MgSO4 with placebo.

Data collection and analysis: Two review authors screened the results of the search and independently extracted data from studies meeting the inclusion criteria. We resolved disagreements through discussion and contacted study authors in cases of missing data and other uncertainties relating to the studies.We analysed dichotomous data as odds ratios and continuous data as mean differences, both using fixed-effect models. We assessed each study for risk of bias and rated the quality of evidence for each outcome with GRADE and presented the results in a 'Summary of findings' table. There was insufficient evidence to conduct the planned subgroup analyses.

Main results: Five studies (182 children) met the inclusion criteria, and four contributed data to at least one meta-analysis. The included studies were overall at low risk of bias, but our confidence in the evidence was generally low, mainly due to the small sample sizes. Treatment with IV MgSO4 reduced the odds of admission to hospital by 68% (odds ratio (OR) 0.32, 95% confidence interval (CI) 0.14 to 0.74; children = 115; studies = 3; I(2) = 63%). This result was based on data from just three studies including 115 children. Meta-analysis for the secondary outcomes was extremely limited by paucity of data. We performed meta-analysis for the outcome 'return to the emergency department within 48 hours', which showed a very imprecise effect estimate that was not statistically significant (OR 0.40, 95% CI 0.02 to 10.30; children = 85; studies = 2; I(2) = 0%). Side effects and adverse events were not consistently reported and meta-analysis was not possible, however few side effects or adverse events were reported.

Authors' conclusions: IV MgSO4 may reduce the need for hospital admission in children presenting to the ED with moderate to severe exacerbations of asthma, but the evidence is extremely limited by the number and size of studies. Few side effects of the treatment were reported, but the data were extremely limited.

PubMed Disclaimer

Conflict of interest statement

Benedict Griffiths: None known

Kayleigh Kew: None known

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011050

References

References to studies included in this review

Ciarallo 1996 {published and unpublished data}
    1. Chandra J. Intravenous magnesium sulfate: a new weapon against acute asthma?. Indian Pediatrics 1997;34(5):459‐60. - PubMed
    1. Ciarallo L, Sauer A, Shannon M. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized placebo controlled trial. Journal of Asthma 1998;35(1):129‐30. - PubMed
    1. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo‐controlled trial. Journal of Pediatrics 1996;129(6):809‐14. - PubMed
Ciarallo 2000 {published and unpublished data}
    1. Ciarallo L, Brousseau D, Reinert S. Higher‐dose intravenous magnesium therapy for children with moderate to severe acute asthma. Archives of Pediatrics and Adolescent Medicine 2000;154(10):979‐83. - PubMed
Devi 1997 {published and unpublished data}
    1. Devi PR, Kumar L, Singhi SC, Prasad R, Singh M. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatrics 1997;34(5):389‐97. - PubMed
Gürkan 1999 {published and unpublished data}
    1. Gürkan F, Haspolat K, Boşnak M, Dikici B, Derman O, Ece A. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. European Journal of Emergency Medicine 1999;6(3):201‐5. - PubMed
Scarfone 2000 {published and unpublished data}
    1. Scarfone RJ, Loiselle JM, Joffe MD, Mull C, Stiller S, Thompson K, et al. Magnesium sulfate in the emergency department treatment of acute asthma in children. Pediatrics 1998;102(3):711.
    1. Scarfone RJ, Loiselle JM, Joffe MD, Mull CC, Stiller S, Thompson K, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Annals of Emergency Medicine 2000;36(6):572‐8. - PubMed

References to studies excluded from this review

Bijani 2001 {published data only}
    1. Bijani KH, Moghadamnia AA, Islami Khalili E. Intravenous magnesium sulfate as an adjunct in the treatment of severe asthmatic patients non‐responding to conventional therapy. Acta Medica Iranica 2001;39(4):219‐21.
    1. Bijani KH, Moghadamnia AA, Islami Khalli E. Intravenous magnesium sulfate as an adjunct in the treatment of severe asthmatic patients non‐responding to conventional therapy. The Internet Journal of Asthma, Allergy and Immunology 2002;2:1.
Bilaceroglu 2001 {published data only}
    1. Bilaceroglu S, Akpinar M, Tiras A, Celikten E, Kalenci D, Perim K. Intravenous magnesium sulphate in acute asthma. Annual Thoracic Society 97th International Conference; 2001 May 18‐23; San Francisco. 2001.
Boonyavorakul 2000 {published data only}
    1. Boonyavorakul C, Thakkinstian A, Charoenpan P. Intravenous magnesium sulfate in acute severe asthma. Respirology (Carlton, Vic.) 2000;5(3):221‐5. - PubMed
del Castillo Rueda 1991 {published data only}
    1. Castillo Rueda A, Recarte García‐Andrade C, Torres Segovia FJ. Magnesium, the 4th drug in asthma treatment?. Revista Clinica Espanola 1991;189(5):250. - PubMed
Irazuzta 2016 {published data only}
    1. Irazuzta J, Pavlovich V, Paredes F. High dose magnesium sulfate infusions in children with status asthmaticus in the emergency department, efficacy study. Pediatric Critical Care Medicine 2014;15(4 Suppl 1):99. [CRS: 4900126000019638]
    1. Irazuzta JE, Paredes F, Pavlicich V, Dominguez SL. High‐dose magnesium sulfate infusion for severe asthma in the emergency department: efficacy study. Pediatric Critical Care Medicine 2016;17(2):e29‐33. - PubMed
Liang 1998 {published data only}
    1. Liang XG. Analysis of the effect of magnesium sulfate in the treatment of asthmatoid disease. Chinese Journal of Modern Medicine 1998;8(2):29.
Okayama 1987 {published data only}
    1. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA 1987;257(8):1076‐8. - PubMed
Santana 2001 {published and unpublished data}
    1. Santana JC, Barreto SSM, Piva JP, Garcia PC. Randomized clinical trial of intravenous magnesium sulfate versus salbutamol in the early management of severe acute asthma in children. Jornal de Pediatria 2001;77(4):279‐87. - PubMed
Singhi 2011 {published and unpublished data}
    1. Singhi S, Bansal A, Chopra K, Grover S. Randomized comparison of magnesium sulfate, terbutaline and aminophylline infusion in acute severe asthma in children. Pediatric Critical Care Medicine 2011;12(3 Suppl):A1.
    1. Singhi S, Bansal A, Chopra K, Grover S. Randomized comparison of magnesium sulfate, terbutaline and aminophylline infusion in acute severe asthma in children [Abstract]. Critical Care Medicine 2010;38(12 Suppl):Poster 371.
    1. Singhi S, Grover S, Bansal A, Chopra K. Randomised comparison of intravenous magnesium sulfate, terbutaline and aminophylline for children with acute severe asthma. Acta Paediatrica 2014;103(12):1301–6. [CRS: 4900126000018343] - PubMed
Skobeloff 1989 {published data only}
    1. Skobeloff EM, Spivey WH, McNamara RM, Greenspoon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989;262(9):1210‐3. - PubMed
Torres 2012 {published and unpublished data}
    1. Torres S, Sticco N, Bosch JJ, Iolster T, Siaba A, Rocca Rivarola M, et al. Effectiveness of magnesium sulfate as initial treatment of acute severe asthma in children, conducted in a tertiary‐level university hospital: a randomized, controlled trial. Archivos Argentinos de Pediatria 2012;110(4):291‐6. - PubMed
Watanatham 2015 {published data only}
    1. Watanatham S, Pongsamart G, Vangveeravong M, Daengsuwan T. Comparison efficacy and safety of inhaled magnesium sulfate to intravenous magnesium sulfate in childhood severe asthma exacerbation. Journal of Allergy and Clinical Immunology 2015;135(2 Suppl 1):AB241. [CENTRAL: 1051042; CRS: 4900126000026528; EMBASE: 71789737]

References to studies awaiting assessment

Abd El Kader 1997 {published data only}
    1. Abd El Kader F. Ventilatory, cardiovascular and metabolic responses to salbutamol, ipratropium bromide and magnesium sulfate in bronchial asthma: comparative study. Alexandria Medical Journal 1997;39(1):43‐64.

References to ongoing studies

NCT01522040 {published and unpublished data}
    1. NCT01522040. Pilot study of magnesium infusions in pediatric asthma. http://clinicaltrials.gov/show/NCT01522040 (accessed 18 August 2014).

Additional references

Asthma UK
    1. Asthma UK. Asthma facts and FAQs. http://www.asthma.org.uk/asthma‐facts‐and‐statistics (accessed 8 October 2013).
BTS/SIGN 2014
    1. British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN). SIGN 141. British guideline on the management of asthma. https://www.brit‐thoracic.org.uk/document‐library/clinical‐information/asthma/btssign‐ast... (accessed 22 February 2016).
Cairns 1996
    1. Cairns CB, Krafi M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Academic Emergency Medicine 1996;3(12):1093‐7. - PubMed
Cheuk 2005
    1. Cheuk DKL, Chau TCH, Lee SL. A meta‐analysis on intravenous magnesium sulphate for treating acute asthma. Archives of Diseases in Childhood 2005;90:74‐7. - PMC - PubMed
GINA 2015
    1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11.pdf (accessed 22 February 2016).
Goodacre 2013
    1. Goodacre S, Cohen J, Bradburn M, Gray A, Benger J, Coats T. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial):a double‐blind, randomised controlled trial. The Lancet Respiratory Medicine 2013;1:293‐300. - PubMed
GRADEpro GDT [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Version 22 April 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Griffiths 2013
    1. Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD000060.pub2] - DOI - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kew 2014
    1. Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD010909.pub2] - DOI - PMC - PubMed
Lyttle 2015
    1. Lyttle M, O'Sullivan R, Doull I, Hartshorn S, Morris I, Powell C. Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: an international survey of clinician practice. Archives of Diseases in Childhood 2015;100(2):121‐5. - PubMed
Millet 2013
    1. Millet C, Lee J, Laverty A, Glantz S, Majeed A. Hospital admissions for childhood asthma after smoke‐free legislation in England. Pediatrics 2013;131(2):496‐501. - PMC - PubMed
NRAD 2014
    1. Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. London: RCP, 2014.
Nyman 2011
    1. Nyman A, Durward A. Asthma in PICU. Paediatric Intensive Care Audit Network National Report 2008 ‐ 2010 (published September 2011): Universities of Leeds and Leicester 2011.
Ohn 2014
    1. Ohn M, Jacobe S. Magnesium should be given to all children presenting to hospital with acute severe asthma. Paediatric Respiratory Reviews 2014;15:319‐21. - PubMed
Powell 2012
    1. Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp‐Sihota JA, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD003898.pub5] - DOI - PubMed
Powell 2013
    1. Powell C, Kolamunnage‐Dona R, Lowe J, Boland A, Petrou S, Doull I, et al. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo‐controlled trial. The Lancet Respiratory Medicine 2013;1(4):301‐8. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rowe 2001
    1. Rowe BH, Spooner C, Ducharme F, Bretziaff J, Bota G. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002178] - DOI - PubMed
Shan 2013
    1. Shan Z, Rong Y, Yang W, Wang D, Yao P, Xie J, et al. Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: A systematic review and meta‐analysis. Respiratory Medicine 2013;107:321‐30. - PubMed
Spivey 1990
    1. Spivey WH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Annals of Emergency Medicine 1990;19(10):1107‐12. - PubMed
Teoh 2012
    1. Teoh L, Cates C, Hurwitz M, Acworth JP, Asperen P, Chang AB. Anticholinergic therapy for acute asthma in children. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD003797.pub2] - DOI - PMC - PubMed

References to other published versions of this review

Griffiths 2014
    1. Griffiths B, Kew KM, Michell CI, Kirtchuk L. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD011050] - DOI - PMC - PubMed
Rowe 2000
    1. Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001490] - DOI - PMC - PubMed

Publication types